抗 HER2 反应性疾病患者：定义和辅助治疗。
Patients with anti-HER2 responsive disease: definition and adjuvant therapies.
机构信息
Dana-Farher Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA.
出版信息
Breast. 2011 Oct;20 Suppl 3:S132-4. doi: 10.1016/S0960-9776(11)70310-1.
Abstract
Treatment of HER2 positive breast cancer is one of the great successes in recent breast oncology. This article will review recent information on patient and tumor selection for anti-HER2 therapy, and new data on optimal use of trastuzumab-based treatments in the adjuvant setting.
摘要
治疗人表皮生长因子受体 2（HER2）阳性乳腺癌是近年来乳腺癌肿瘤学的重大成就之一。本文将回顾近期关于抗 HER2 治疗患者和肿瘤选择的信息，以及辅助治疗中基于曲妥珠单抗的治疗最佳应用的新数据。
Zotero 插件